Tag - CSTL

Markets

BTIG ups Castle Biosciences PT to $41 from $32

BTIG raised its price target for Castle Biosciences (NASDAQ:CSTL) to $41 from $32 after the company reported fourth quarter results and initial revenue guidance for 2020. The stock closed at $29.36 on March 10. Castle...

March 11, 2020

Markets

Analysts start Castle Biosciences at buy and OP with PTs of $25-to-$28

Analysts for SVB Leerink, BTIG and Canaccord Genuity launched coverage of Castle Biosciences (NASDAQ:CSTL), saying the company answers a large unmet need in skin cancer. The stock closed at $20.25 on Aug. 16. SVB...

August 19, 2019

Tag - CSTL

BTIG ups Castle Biosciences PT to $41 from $32

Analysts start Castle Biosciences at buy and OP with PTs of $25-to-$28

General

More